Article Information
History
- November 5, 2019.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Bartek Nogal1,8,
- Laura E. McCoy2,8,
- Marit J. van Gils3,
- Christopher A. Cottrell1,
- James E. Voss4,5,6,
- Raiees Andrabi4,5,6,
- Matthias Pauthner4,5,6,
- Chi-Hui Liang4,5,6,
- Terrence Messmer4,5,6,
- Rebecca Nedellec4,5,6,
- Mia Shin1,
- Hannah L. Turner1,
- Gabriel Ozorowski1,5,6,
- Rogier W. Sanders3,
- Dennis R. Burton4,5,6,7,* and
- Andrew B. Ward1,5,6,9,*
- 1Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA 92037, USA
- 2Division of Infection and Immunity, UCL, London, UK
- 3Department of Medical Microbiology, Amsterdam UMC, Location AMC, University of Amsterdam, 1105AZ, Amsterdam, The Netherlands.
- 4Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037, USA
- 5International AIDS Vaccine Initiative - Neutralizing Antibody Center (IAVI-NAC), The Scripps Research Institute, La Jolla, CA 92037, USA
- 6Center for HIV/AIDS Vaccine Development (CHAVD), The Scripps Research Institute, La Jolla, CA 92037, USA
- 7Ragon Institute of MGH, MIT and Harvard, Cambridge, MA0239, USA
- ↵*Correspondence: burton{at}scripps.edu, andrew{at}scripps.edu
↵8 These authors contributed equally